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Wide clinical application of intravascular stenting 
devices is currently limited by occlusion or intra- 
luminal narrowing caused by thrombosis and 
neointimal thickening in a considerable percent- 
age of implantations. We studied the possibility of 
seeding one of the currently availiable stents, a 
stainless steel, sel$expandable wire-mesh, with 
endothelial cells in vitro. Endothelial cells, derived 
from human umbilical cord veins, could be suc- 
cessfully attached to stent filaments. In vivo stent 
implantations in porcine femoral arteries showed 
complete covering of stent wires by endothelium 
ajter 1 week. We conclude that coating of stents 
with autologous endothelial cells prior to implan- 
tation might protect against early thrombosis dur- 
ing the period in which a neointima is formed. (J 
Interven Cardiol 1988: 1:2) 
Introduction 
Invasive therapy for atherosclerotic vascular 
disease has gradually shifted from surgery to a 
choice between surgery and angioplasty. Intralu- 
minal stenting with vascular endoprostheses was 
already attempted in the early days of balloon an- 
gioplasty for the treatment of procedure-related 
complications and the prevention of restenosis.' 
Narrowing of the stented segment caused by 
neointimal hyperplasia limited the use of these de- 
vices even in the larger (peripheral) arteries. 
Changes in design, the use of other metal alloys, 
and miniaturization of the endoprostheses now 
yielded several stents for experimental and clinical 
Studies of peripheral and coronary 
arteries in sheep and dogs have, however, shown 
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that thrombosis still occurs in 20%-30% of the 
stents, in particular during the first 14 days after 
implantati~n.~.~ This may be related to the lack of 
a protective endothelial covering. Thrombosis 
occurs in these animals between 2 weeks and 3 
months after implantation. Effective measures 
should be taken during the period between im- 
plantation and neointimal covering to prevent the 
incidence of thrombosis. In the present study we 
show that seeding stents with endothelial cells may 
be such a measure. 
Materials and Methods 
In Vitro Endothelialization of Stent 
Harvesting endothelium from human umbilical 
veins. Immediately after delivery the umbilical 
cord vein was cannulated and flushed with Hepes- 
buffered saline. Thereafter the vein was filled with 
medium containing 0.1% collagenase and incu- 
bated for 20 min at 37°C. Then the vein was 
flushed with medium and the cell-suspension col- 
lected in plastic tubes. After centrifugation for 5 
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min at 125 g, the cell pellet was resuspended in 
Medion M 199 (Flow Laboratories Ltd, Irvine, 
Scotland) supplemented with serum and growth 
factors and cultured in a flask coated with fibron- 
ectine ( 10 pg/cm2) for 2  day^.^,^ 
Description of the Stent. The stent used (Wall- 
stentR, Medinvent SA, Lausanne, Switzerland) 
was a stainless-steel, open-weave wire-mesh (Fig. 
1). The prosthesis is self-expanding and its elastic 
properties are such that its diameter can be sub- 
stantially reduced by elongation. It can thus be 
constrained on a small-diameter delivery catheter, 
which consists of two coaxial catheters, the proxi- 
mal regions of which are joined by an invaginated 
rolling membrane, which effectively retains the 
prosthesis. Withdrawal of the outer catheter rolls 
back the membrane progressively, thus releasing 
the stent, which tends to return to its orginal diam- 
eter, thereby anchoring itself against the arterial 
wall. The unconstrained diameter of the stent used 
in this study was 3.5 mm and the length 15 mm. 
Coating the Stents with Endothelium. The un- 
constrained stents were incubated with fibronec- 
tine (100 pg/mL) for 15 min at 37°C for support of 
endothelial coverage. Endothelial cell suspensions 
(derived as above) were brought together with the 
stent in a small siliconized glass tube and rotated 
(2 rpm) for 2 hours at 37°C. Subsequently, the 
stent with cells were transferred to a petri dish, 
covered with medium and cultured overnight. For 
the coating of 1 cm stent (diameter 3.5 mm) about 
50,000 endothelial cells were used. The cells on the 
stent were stained with the vital DNA-stain 
Hoechst 33342 (Hoechst AG, Frankfort, FRG) (10 
uM; 1 hour; 37°C) or with the vital dye fluores- 
cence diacetate (Serva, Heidelberg, FRG) (0.1 
pg/mL, 10 min; 37°C). Other stents were fixed 
with buffered glutaraldehyde (3%) and stained 
Figure 1. Scanning electron microscopic picture (magnification 550X) of stent wires seeded in vitro with cultured endothelial cells derived 
from umbilical cord veins. The flattened cells are in close contact. 
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with the nuclear stain propidium iodide (Sigma, St 
Louis, MO, USA) (10 pg/mL). The cell-covered 
stents were observed with a fluorescence micro- 
scope with epi-illumination. 
Coating the Stents Mounted on the Delivery 
Catheter. First the fibronectine solution and then 
the endothelial cell suspension was drained by ap- 
plying a minimal suction at the central catheter of 
the stent-loaded delivery system. After sealing the 
tip of the stent-delivery catheter by a sterile glove 
covered finger the suspension was advanced 
through the pores of the central catheter until it 
had replaced the air around the stent filaments. 
Then the mounted stent was incubated overnight. 
The next day the stent was released from the cath- 
eter and placed in fluorescent dye (propidium io- 
dide, 10 pg/mL) after fixation in phosphate buf- 
fered 3% glutaraldehyde. 
In Vivo Endothelialization of Stents. In 6 young 
Yorkshire swine (18-25 kg) a total number of 18 
stents were implanted. After sedation with 500 mg 
of ketamine hydrochloride (Aescoket,R Aesculaap 
BV, Boxtel, Holland) the animals were connected 
to a respirator for artificial ventilation with a mix- 
ture of oxygen and nitrous oxide, after endotra- 
cheal intubation. Anesthesia was maintained with 
1-4 vol% enflurane (Ethrane,R Abbott BV, Am- 
stelveen, Holland) while pancuronium bromide 
(PavuloqR Organon, Oss, Holland) was used as a 
muscle relaxant. 
An 8F introduction sheath was placed via the 
left carotid artery in the descending aorta. After 
Figure 2. Fluorescence microscopy of stent Wires coated with endothelial cells stained with the vital DNA stain Hoechst 33342. The nuclei of the umbilical 
cord vein derived cells are uniformly distributed and abundant on the metal alloy filaments (magnification 200X). 
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intravenous administration of 5,000 IU heparin 
and 100 mg aspirin (Aspegic.R Lorex, Weesp, Hol- 
land), an 8F guiding catheter was advanced to the 
aorto-iliac bifurcation. 
After baseline angiography of both femoral ar- 
teries a 300 cm, 0.014 inch long guidewire was 
placed in the left femoral artery. Over the guide- 
wire an angioplasty balloon catheter (balloon size 
3.5 mm) was advanced. From the angiograms, and 
using the diameter of the guide catheter as a refer- 
ence, a segment of the left femoral artery was cho- 
sen with a diameter of 3.0 mm. At that point the 
angioplasty balloon was inflated twice for 60 sec 
and 10 Atm inflation pressure. Then the angio- 
112 
Figure 3A. X-ray of the stent (arrow) unplanted in the left femoral artery. 
Journal of Interventional Cardiology Vol. 1, No. 2, 1988 
ENDOTHELIALIZATION OF INTRAVASCULAR STENTS 
plasty catheter was withdrawn, and angiography 
was repeated. The stent constrained delivery cath- 
eter, with an endoprosthesis mounted on its tip 
was positioned over the long guidewire at the di- 
lated arterial segment. After the stent was released, 
catheters and guidewire were withdrawn to the 
aortic bifurcation, and repeat angiography was 
performed. The same procedure was followed for 
placement of a stent in the right (contralateral) 
femoral artery, except that at this site angioplasty 
was not performed. The catheters were removed, 
and the animals allowed to recover. 
Figure 3B. Angiogram 10 days after implantation. The stent related artery is patent without signs of intraluminal 
defects. 
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Starting the day of the procedure animals 1 and 
2 received calciparin 25,000 IU subcutaneously 
daily until acenocoumarol had prolonged the 
prothrombin time three-fold. Aspirin 100 m1/24 h 
intravenously was also added. The other animals 
received only 100 mg of aspirin in one daily oral 
dose. After 6 days (animals 1 and 2; 8 stents), 8 
days (animals 3-5; 6 stents) and 10 days (animal 6; 
4 stents), the animals were again anesthetized, and 
angiography of the stent-related arteries was per- 
formed. Immediately thereafter the stent-contain- 
ing arterial segments were dissected free, perfused 
in vivo with saline (perfusion pressure 75 mmHg) 
and removed. Thereafter the animals were sacri- 
ficed with an overdose of pentobarbitone sodium. 
The stent-containing arterial segments were placed 
in buffered glutaraldehyde for subsequent electron 
microscopy. 
Electron Microscopy. After fixation in 4% for- 
maldehyde and 1 % glutaraldehyde in 0.1 M caco- 
dylate buffer (pH 7.3) for at least 48 hours, the 
stent containing arterial segments were washed in 
cacodylate buffer and divided lengthwise into two 
equal parts using a pair of fine scissors. One half of 
the stent underwent postfixation for 6 hours in 1% 
osmium tetroxide, and washing overnight in dis- 
tilled water, and dehydration in graded ethanol 
and critical point drying with liquid C02. This part 
of each vessel was mounted and sputtercoated with 
gold before examination in a scanning electron mi- 
croscope (Cambridge 180 steroscan, Cambridge, 
U.K.). 
From the other half of each vessel the stent wires 
were removed and the tissue was prepared for light 
microscopy. 
Hematologic Measurements. Before administra- 
tion of the anticoagulants, at the end of the im- 
plantation procedure and again after 2 and 6 days 
of recovery, 10 mL arterial blood was collected in a 
syringe containing sodium citrate (final concen- 
Figure 4. Scanning electron micrograph (magnification 1,250X) of porcine femoral arterial segment 5 days after stent implanta- 
tion. The wires are covered by a neointima with spindle shaped endothelial cells on the surface. Fissures in the endothelial layer 
are caused by this fixation procedure. 
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tration 11 mM) for determination of the platelet 
count, recalcification time, and prothrombin time. 
Results 
In Vitro Endothelialization. Harvesting endo- 
thelium from human umbilical cord veins yielded 
approximately 2.105 cells per vein (10-15 cm). 
After culturing these cells for 4 days about lo6 cells 
were available for seeding the stent. Incubation of 
these cells with the isolated stent for 2 hours and 
subsequent culturing resulted in an almost com- 
plete blanketing of the inner surface of the stent 
wires by flattened endothelial cells (Fig. 1). 
Fluorescence staining of endothelial nuclei with 
Hoechst 33342 showed a uniform distribution of 
the cells on the stent wires (Fig. 2). Incubation of 
the stent mounted on the delivery catheter with 
isolated endothelium for 2 hours resulted in a sim- 
ilar endothelial lining. However, the inner surface 
proved to be covered for only approximately 50% 
after the stent had been released. 
In Vivo Endothelialization in Porcine Femoral 
Arteries. All implanted stents remained patent 
during the period after implantation (6-10 days). 
Angiograms obtained at the end of the observation 
period showed no signs of stent-displacement, 
while stent-related intraluminal defects (consid- 
ered to be caused by thrombus) could not be dem- 
onstrated in any of the implants (Fig. 3).  Scanning 
electron microscopy showed that the stents were 
completely covered by an endothelial lining as 
early as 6 days after implantation (Fig. 4). No dc- 
position of platelet aggregates or thrombus mate- 
rial was observed on the neointimal lining. Trans- 
Figure 5A. Light microscopy of stented porcine femoral artery 3 days after implantation (magnification 190 X). The empty spaces 
correspond with the stent wires. At the site of the stent filaments the media is considerably compressed, while the internal elastic lamina is 
interrupted. 
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mission microscopy showed that the stent fila- 
ments compressed the arterial media (Fig. 5A), 
with disruption of the internal elastic lamina 
(FigsSA and 5B). A neointima of varying thick- 
ness covered the stent wires. While normal femo- 
ral arteries showed a thin intimal layer (5 pm), the 
median thickness of the stent covering neointima 
was 80 pm (range 60-125 pm). The neointima was 
covered with endothelial cells (Fig. 5C). In the 
neointima directly underneath the endothelium a 
Figure 5B. (detail of 5A, magnification 5 lox) In the neointima myofibrillar cells and macro- 
phages are abundant. In the vicinity of this stent filament many trapped erythrocytes can be 
seen. 
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Figure 5C. (detail of 5A, magnification 5 lox) The neointima is covered by a continuous layer of endothelial cells. Between the endothelium 
and the stent many fibroblast-like cells can be seen, together with trapped erythrocytes and fibrous material. 
mixture of fibers, trapped red blood cells and mac- 
rophage-type cells were present (Figs. 5B and 5C). 
Fibrous material, probably consisting of fibrin, oc- 
cupied small areas between the stent filament and 
new intima. The presence of this fibrous material 
and the entrapped cells suggests that some deposi- 
tion of thrombotic material might have occurred 
before the development of the neointima was 
completed. 
No differences in ultrastructural appearance 
could be demonstrated between arterial segments 
that had been subjected to balloon angioplasty and 
those segments which were not dilated. 
Hematological Data. The results of the hemato- 
logical measurements are summarized in Table 1. 
During recovery prothrombin time and recalcifi- 
cation time were significantly prolonged in the an- 
imals receiving extensive anticoagulant therapy. In 
the animals receiving only aspirin, these values 
were normal again 2 days after implantation. 
Dissussion 
The application of percutaneous transluminal 
coronary angioplasty (PTCA) for the treatment of 
coronary artery disease has increased considerably 
in recent years. The initial success rate is 
with only a small incidence of acute or subacute 
occlusion at the site of angiop1a~ty. l~~~~ However, 
restenosis several months after the procedure re- 
mains an unsolved problem with an incidence of 
20%-40%.1"'6 The effect of pharmacological ther- 
apy on acute  complication^'^-^^ and late resteno- 
sisZo is still unclear. The implantation of vascular 
endoprostheses after angioplasty to prevent these 
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Table 1. Hematological Parameters of Pigs with Stents Implanted in the Femoral Arteries 
Prothrombin Recalcification Platelet Count 
Time (s) Time (min) (mm-3) 
group 1 25 k 3 2.5 f 0.3 255 & 32 
group 2 2 5 k  I 2.3 f 0.3 305 f 44 
Baseline 
End implantation >180 30 f 2 
>15 
> I 5  
297 f 51 
266 f 4 3  
group 1 2180 >15 261 f 7 
group 2 2 5 f  I 1.5 f 0.3 314 f 52 
group 1 1180 2 1 5  288 f 28 
group 2 2 4 f  1 1.6 f 0.3 286 f 21 
Day 2 
Day 6 
Group 1 (animals 1 and 2) received the extensive anticoagulant therapy; group 2 (animals 3-6) received only aspirin after implanta- 
tion. All data have been presented as mean f SEM. 
sequelae in patients with coronary atherosclerosis 
has proven feasible.2’ Whether this technique actu- 
ally reduces the incidence of restenosis is as yet 
unknown. Observations in a small number of pa- 
tients show that the implantation of an endo- 
prosthesis after balloon angioplasty causes an im- 
mediate slight further dilatation of the arterial seg- 
ment.22 However, after 3 months a small but 
significant diffuse narrowing of the stented artery 
was observed.23 
Implantations of such endoprostheses in periph- 
eral and coronary arteries in sheep and dogs 
showed early thrombotic complications (< 14 
days) in 20%-30%.6,7 This percentage can proba- 
bly be reduced by avoiding some “thrombogenic” 
implantation parameters such as diameter mis- 
match between stent and receiving artery, stent 
margin at side-branch, low flow through the 
stented vessel and administration of low doses of 
aspirin ( 5  mg/kg) after implantation as in the 
present study. In vascular surgery comparable 
problems are encountered. Proposed solutions by 
this discipline comprise the design of nonthrom- 
bogenic vascular grafts, or seeding the graft surface 
with autologous endothelial cells. Cell-seeding 
might be the better solution, as this provides an 
active antithrombotic graft surface.24 Metal-alloy 
vascular endoprostheses currently available share 
the advantage, contrary to polymer surface vascu- 
lar grafts, of macroporosity, covering up to 20% of 
the vascular surface area. This will allow earlier 
covering of the stent filaments with native endo- 
thelium. Endothelial covering was reported after 
10 days to 8 weeks dependent upon the species, 
type of stent, size of receiving vessel and whether 
or not atherosclerotic lesions were 
In the present study it was shown that stents placed 
in porcine femoral arteries were already covered 
with neointima after 6 days. This faster rate of 
neointimal generation may be related to age and 
species of the animals.28Prior balloon angioplasty, 
which has been shown to cause effective endothe- 
lid denudation in the same did not seem 
to delay this process. The thickness of the neoin- 
tima in the present study (80 pm) is comparable to 
data reported by others in the same species 8 weeks 
after implantati~n,~~Data reported for dog im- 
plantations seem more variable. After 1 to 3 weeks 
mean neointimal thicknesses of 80 to 300 pm have 
been r e p ~ r t e d . ~ , ~ ~ . ~ ~  After 6- 12 months these 
values were 270-450 pm.7*27 Although one should 
be cautious in comparing results obtained in dif- 
ferent species with different types of stents, and 
while most authors do not specify their measure- 
ments, the conclusion seems justified that neointi- 
mal thickening progresses gradually. 
In man endothelial covering of vascular proth- 
esis occurs much slower than in the pig.28 Accord- 
ingly the prosthesis is subjected to prothrombotic 
forces for a longer duration. This might imply the 
need for chronic antithrombotic treatment or 
other alternatives. Cell-seeding the stents might be 
that alternative. In the present study one of the 
clinically most relevant stents can be covered by 
endothelial cells in vitro, after relatively simple 
and nontime consuming measures. Scanning elec- 
tron microscopy shows that the endothelial cells 
are flattened with close cell-to-cell contact. 
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Whether these cells remain attached to the stent 
after intra-arterial placement depends upon the 
shear resistance, which has to be studied in further 
experiments. Furthermore it has to be established 
whether the cells remain viable and metabolically 
active, considering the dependence of the cells on 
endothelial cell growth factor. This dependence 
might be related to cell density in culture, but 
more data are needed to establish this. The use of 
autologous endothelial cell suspensions harvested 
from subcutaneous fat biopsies, avoids the need 
for tissue typing and the risk of cell rejection. 
In conclusion, our study showed an early time- 
span wherein endovascular stents were covered by 
a neointima. Present data suggest that stents are at 
risk for partial or complete thrombotic occlusion 
during at least the first 6 days after implantation. 
Cell-seeding of the stent filaments, to obtain an 
active antithrombotic stent surface, seems an at- 
tractive method to reduce this risk. In vitro experi- 
ments demonstrated that stents can be covered by 
a substantial number of endothelial cells within 
hours. These data strongly suggest further in vivo 
experiments to investigate whether this approach 
may contribute to the solution of a major problem 
in current cardiologic interventions. 
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